EXPRESSION OF HER2 IN RECTAL CANCER WITH PREOPERATIVE RADIOTHERAPY POTENTIAL BIOMARKER TO PREDICT THE METASTASIS

被引：0
|
作者：
Yao, Y.
Du, C.
Chen, P.
Chen, N.
Gu, J.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2013年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E89 / E90
页数：2
相关论文
共 50 条
  • [1] Expression of HER-2 in Rectal Cancers Treated With Preoperative Radiotherapy: a Potential Biomarker Predictive of Metastasis
    Yao, Yun-Feng
    Du, Chang-Zheng
    Chen, Nan
    Chen, Pengju
    Gu, Jin
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : 602 - 607
  • [2] HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
    Sanghoon Han
    Sungjin Park
    Jungsuk An
    Jun-Young Yang
    Jun-Won Chung
    Yoon Jae Kim
    Kyoung Oh Kim
    Dong Kyun Park
    Kwang An Kwon
    Woon Kee Lee
    Seungyoon Nam
    Jung Ho Kim
    Scientific Reports, 10
  • [3] HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
    Han, Sanghoon
    Park, Sungjin
    An, Jungsuk
    Yang, Jun-Young
    Chung, Jun-Won
    Kim, Yoon Jae
    Kim, Kyoung Oh
    Park, Dong Kyun
    Kwon, Kwang An
    Lee, Woon Kee
    Nam, Seungyoon
    Kim, Jung Ho
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [4] Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer
    Lu, Yuanming
    Gao Jingyan
    Song Baorong
    Peng, Junjie
    Xu, Ye
    Cai, Sanjun
    CANCER BIOMARKERS, 2012, 11 (05) : 219 - 226
  • [5] Evaluation of Her2 RNA expression as a potential predictive biomarker for anti-Her2 therapy
    Lamb, Laura E.
    Khazanov, Nickolay A.
    Hovelson, Daniel H.
    Kwiatkowski, Kat
    Johnson, D. Bryan
    Rhodes, Daniel R.
    Tomlins, Scott A.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] HER2 expression in cervical cancer as a potential therapeutic target
    Alma Chavez-Blanco
    Victor Perez-Sanchez
    Aurora Gonzalez-Fierro
    Teresa Vela-Chavez
    Myrna Candelaria
    Lucely Cetina
    Silvia Vidal
    Alfonso Dueñas-Gonzalez
    BMC Cancer, 4
  • [7] Serum HER2 as potential prognostic biomarker in primary breast cancer patients
    Todorovic-Rakovic, Natasa
    Milovanovic, Jelena
    Radulovic, Marko
    Greenman, John
    GROWTH FACTORS, 2025,
  • [8] HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
    Andre, Fabrice
    Mazouni, Chafika
    Liedtke, Cornelia
    Kau, Shu-Wan
    Frye, Debby
    Green, Marjorie
    Gonzalez-Angulo, Ana M.
    Symmans, W. Fraser
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 183 - 190
  • [9] HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
    Fabrice Andre
    Chafika Mazouni
    Cornelia Liedtke
    Shu-Wan Kau
    Debby Frye
    Marjorie Green
    Ana M. Gonzalez-Angulo
    W. Fraser Symmans
    Gabriel N. Hortobagyi
    Lajos Pusztai
    Breast Cancer Research and Treatment, 2008, 108 : 183 - 190
  • [10] Clinical relevance of HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy
    Seo, An Na
    Yoon, Ghilsuk
    Chhun, Vireak
    Kim, Hye Jin
    Park, Jong Min
    Park, Jun Seok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 147 - 147
12345